Answers from the Lab cover art

All Episodes

Answers from the Lab — 385 episodes

#
Title
1

Lab Outreach Delivers Value, Growth, and Strategic Advantage

2

Personalized Therapy Growth Driven by Clinical Diagnostics

3

How Pharmacogenomics Deliver More Precise Cancer Therapy

4

Risks Increase as Ticks, Mosquitoes, and Similar Vectors Spread

5

Lab Stewardship in Modern Healthcare

6

Unique Assays Advance Care of Complex Autoimmune Skin Conditions

7

Digital Advances: What’s Next for Clinical Diagnostics?

8

Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes

9

Breakthrough Test Enhances Peripheral Neuropathy Care and Research

10

How Strategic Collaborations Transform Clinical Diagnostics

11

Innovation and Resilience in Lab Logistics

12

2026 Forecast: Trends Shaping the Future of Diagnostics

13

Speed Without Sacrifice: How Diagnostics Can Move Quickly and Safely

14

Breakthroughs and Trends That Defined Lab Medicine in 2025

15

Accelerating Research and Development With BioPharma Diagnostics

16

Unlocking the Unknown With Metagenomics

17

Forging Collaborations That Deliver Better Outcomes

18

Advancing Precision Medicine Through Therapeutic Tests

19

Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D.

20

Self-Collection Testing Expands to New Areas: Elitza Theel, Ph.D.

21

Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D.

22

Whole Exome Sequencing Reflex Test Offers Cost-Effective Diagnosis: Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC

23

Rabbits, Chikungunya, and More Viral News: Matthew Binnicker, Ph.D.

24

The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.

25

New Tools for the Changing Landscape of Tick-Borne Diseases: Elitza Theel, Ph.D.

26

How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D.

27

Expanded assay better identifies hereditary pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC

28

How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.

29

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

30

Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D.

31

Advancing Neuropathy Diagnosis With Laboratory Testing and Algorithms: Div Dubey, M.B.B.S

32

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

33

Global Diagnostic Trends and What They Mean for Laboratories: Bill Morice, M.D., Ph.D.

34

Five Ways Laboratories Maximize Health System Success: Bill Morice, M.D., Ph.D.

35

Laboratory Medicine Central to Tick-Borne Disease Response: Bill Morice, M.D., Ph.D.

36

Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.

37

Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D.

38

What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.

39

Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP

40

Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.

41

The Emergence of Retail Health: Bill Morice, M.D., Ph.D.

42

Significant Infectious Disease Activity Continues: Bill Morice, M.D., Ph.D.

43

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.

44

Why a Quality Management Program is Essential: Bill Morice, M.D., Ph.D.

45

Importance of Monitoring Business Trends in Diagnostics: Bill Morice, M.D., Ph.D.

46

Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.

47

Innovations Set to Shape the Industry in 2025: Bill Morice, M.D., Ph.D.

48

Benefits of Automation in the Laboratory: Erin Graf, Ph.D.

49

The Latest on H5 Avian Influenza: Bill Morice, M.D., Ph.D.

50

The Rapid Evolution of Artificial Intelligence: Bill Morice, M.D., Ph.D.

51

Global Vigilance in Preventing Infectious Disease Outbreaks: Bill Morice, M.D., Ph.D.

52

Expanding Lab Access to Improve Health Equity: Bill Morice, M.D., Ph.D.

53

Making Informed Decisions About Genetic Testing: Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC

54

Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.

55

What’s Causing Outbreaks of Preventable Infectious Diseases: Bill Morice, M.D., Ph.D.

56

Preparing for Respiratory Viruses: Bill Morice, M.D., Ph.D.

57

Hypermethylation Test Guides Lynch Syndrome Care: Megan Hoenig, M.S., M.P.H., CGC

58

Navigating Technology Disruptions: John Osborn

59

Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D.

60

The Science of Diagnosing Rare Platelet Disorders: Dong Chen, M.D., Ph.D.

61

Overcoming Health Threats Through Public-Private Lab Partnerships: Bill Morice, M.D., Ph.D.

62

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

63

Advancing Lupus Treatment With Modern Diagnostics: Bill Morice, M.D., Ph.D.

64

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.

65

Novel Laboratory Tests Transform Lupus Management: Bill Morice, M.D., Ph.D.

66

Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

67

Breakthrough Lab Tests for Detecting Alzheimer’s Disease: Bill Morice, M.D., Ph.D.

68

Trends in the Laboratory and Diagnostic Testing Market: Bill Morice, M.D., Ph.D.

69

Why Mpox is a Public Health Emergency: Matthew Binnicker, Ph.D.

70

Tracking the Latest Pathogens: Bill Morice, M.D., Ph.D.

71

Panel Boosts Therapeutic Monitoring of IBD Drug: Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D.

72

Global Industry Activities: Bill Morice, M.D., Ph.D.

73

Alarming Increase in Dengue Cases: Elitza Theel, Ph.D.

74

Scaling Knowledge With AI: Bill Morice, M.D., Ph.D.

75

An Impactful Supreme Court Decision: Bill Morice, M.D., Ph.D.

76

The Metals Laboratory Tests Beethoven’s Hair: Paul Jannetto, Ph.D.

77

COVID-19 and Avian Flu: Bill Morice, M.D., Ph.D.

78

The Platform Transformation of Healthcare: Bill Morice, M.D., Ph.D.

79

Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D.

80

Infectious Diseases on the Move: Bill Morice, M.D., Ph.D.

81

Tests Aid Diagnosis of Cancer-Associated Neurological Disorders: Divyanshu Dubey, M.B.B.S.

82

Get to Know DLMP’s Vice Chair of Research: Peter Lucas, M.D., Ph.D.

83

Avian Flu Outbreaks and New COVID-19 Variants: Matthew Binnicker, Ph.D.

84

Enhanced Solid Tumor NGS Panel Broadens Genetic-Variants Detection: Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S.

85

New Panels Help Find Cause of Rapidly Progressive Dementia: Gregory (Gregg) Day, M.D.

86

Get to Know the DLMP Chair: Eric Hsi, M.D.

87

Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.

88

FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D.

89

The Growing Crisis of Antimicrobial Resistance: Robin Patel, M.D.

90

Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

91

Alzheimer’s Disease and Testing Innovations: Bill Morice, M.D., Ph.D.

92

Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D

93

Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.

94

Assay monitors response to monoclonal antibody therapy: Maria Alice Willrich, Ph.D.

95

Tick Season Outlook: Elitza Theel, Ph.D.

96

Noninvasive plasma biomarker testing provides faster answers: Alicia Algeciras-Schimnich, Ph.D.

97

Dengue Outbreaks and Advancements in Colon Cancer Screening: Bill Morice, M.D., Ph.D.

98

Assay identifies rare tick-borne bacteria: Bobbi Pritt, M.D.

99

Why Measles Is on the Rise: Matthew Binnicker, Ph.D.

100

Targeted panel boosts accuracy of hereditary pancreatitis testing: Experts: Linda Hasadsri, M.D., Ph.D., and Huong T. Cabral, M.S., C.G.C.

101

Industry Updates From the Nation’s Capital: Bill Morice, M.D., Ph.D.

102

Test identifies Lynch syndrome for targeted cancer monitoring: Wei Shen, Ph.D., and Rhianna Urban, M.S., CGC

103

Syphilis Testing Updates: Elitza Theel, Ph.D.

104

Testing aids nicotine-use cessation: Paul Jannetto, Ph.D.

105

Final Rule on LDTs May Be Coming Soon: Bill Morice, M.D., Ph.D.

106

Black History Month: Bill Morice, M.D., Ph.D.

107

Adrenal Gland Tumors: Stefan Grebe, M.D., Ph.D., and Irina Bancos, M.D.

108

Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D.

109

Emerging and Reemerging Diseases: Bill Morice, M.D., Ph.D.

110

Tests aid diagnosis of primary biliary cholangitis: Anne Tebo, Ph.D.

111

Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D.

112

The Pulse on Global Diagnostics: Bill Morice, M.D., Ph.D.

113

Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.

114

Evolution of Syphilis: Elitza Theel, Ph.D.

115

A New Year with Familiar Viruses: Bill Morice, M.D., Ph.D.

116

Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.

117

Test helps identify elusive central nervous system pathogens: Robin Patel, M.D.

118

Unique testing helps identify cause of sudden cardiac death: Linnea Baudhuin, Ph.D., and Kate Kotzer, M.S., CGC

119

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D.

120

The Past, Present, and Future of Diagnostics: Bill Morice, M.D., Ph.D.

121

Assay identifies biomarker of autoimmune encephalitis subtype: Andrew McKeon, M.B., B.Ch., M.D.

122

Milestone Treatments for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

123

Panel offers proactive drug monitoring for IBD: Maria Willrich, Ph.D., and Melissa Snyder, Ph.D.

124

Comments on the FDA’s Proposed Rule: Bill Morice, M.D., Ph.D.

125

Protecting Against Winter Respiratory Viruses: Bill Morice, M.D., Ph.D.

126

Congressional and Federal Updates: Bill Morice, M.D., Ph.D.

127

Perspectives from Washington, D.C.: Bill Morice, M.D., Ph.D.

128

RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D.

129

Safeguards for AI in Healthcare: Bill Morice, M.D., Ph.D.

130

A Possible Cure for Sickle Cell Disease: Bill Morice, M.D., Ph.D.

131

Opportunities Around At-Home Testing: Bill Morice, M.D., Ph.D.

132

How AI Can Add Value to Laboratory Medicine: Bill Morice, M.D., Ph.D.

133

Transformative Technologies: Bill Morice, M.D., Ph.D.

134

Proposed Regulations for Laboratory Developed Tests: Bill Morice, M.D., Ph.D.

135

Seasonal Outlook of Respiratory Viruses: Matthew Binnicker, Ph.D.

136

Circulating Strains of COVID-19: Bill Morice, M.D., Ph.D.

137

What to Know About Leprosy: Nancy Wengenack, Ph.D.

138

Flea-borne Typhus: Elitza Theel, Ph.D.

139

Opioid Addiction and Substance Abuse Testing: Paul Jannetto, Ph.D.

140

Summertime Pathogens: Bill Morice, M.D., Ph.D.

141

Modern-day Outbreaks: Bill Morice, M.D., Ph.D.

142

Test for LDL subtype helps manage coronary risk: Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D.

143

Learning Through Teaching Global Health: Bill Morice, M.D., Ph.D.

144

Panel pinpoints causes of genetic hearing loss: Nicole Boczek, Ph.D., and Melanie Meyer, M.S, CGC

145

Pioneering Research in Autoimmune Neurology: Vanda Lennon, M.D., Ph.D.

146

Breast cancer panel halves turnaround time: Wei Shen, Ph.D.

147

Dengue and Chikungunya Outbreaks: Elitza Theel, Ph.D.

148

Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

149

Malaria in the United States: Bill Morice, M.D., Ph.D.

150

Urologic panels provide focused cancer testing: Sounak Gupta, M.B.B.S., Ph.D.

151

The Latest on Measles: Matthew Binnicker, Ph.D.

152

Results report simplifies urine test interpretation: John Lieske, M.D.

153

FDA Oversight of Lab-Developed Tests: Bill Morice, M.D., Ph.D.

154

Multigene panel provides efficient ataxia diagnosis: Angela Pickart, M.S., CGC, and Emily Lauer, M.S., CGC

155

Remote Diagnostics: Bill Morice, M.D., Ph.D.

156

Updated assay guides diagnosis of autoimmune liver disease: Anne Tebo, Ph.D.

157

Diagnosing Lyme Disease: Bill Morice, M.D., Ph.D.

158

BioPharma Diagnostics: Bill Morice, M.D., Ph.D.

159

The impact of AI: Bill Morice, M.D., Ph.D.

160

West Nile virus: Elitza Theel, Ph.D.

161

The progression of the diagnostic landscape: Bill Morice, M.D., Ph.D.

162

Endemic fungal infections in North America: Elitza Theel, Ph.D.

163

A strong community of lab professionals: Bill Morice, M.D., Ph.D., and Susan Van Meter

164

Test detects autoimmune neurology disorders linked to cancer: Sean Pittock, M.D.

165

Emerging fungal pathogens: Dr. Nancy Wengenack

166

Leading important industry conversations: Bill Morice, M.D., Ph.D.

167

IDH assay facilitates timelier leukemia treatment: Rong He, M.D.

168

Neurofilament light chain: Bjorn Oskarsson, M.D.

169

Approaching tick season: Bill Morice, M.D., Ph.D.

170

An efficient, cost-effective, fungal testing alternative: Elitza Theel, Ph.D.

171

Avian influenza and reflecting on three years of COVID-19: Matthew Binnicker, Ph.D.

172

Test assesses all inherited Parkinson's disease genes: Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D.

173

Neuromuscular gene panel provides comprehensive analysis: Zhiyv (Neal) Niu, Ph.D., and Christopher Klein, M.D.

174

Amplifying the voice of the lab during policymaking: Dr. Bill Morice

175

Whole genome sequencing streamlines diagnosis: Nicole Boczek, Ph.D., and Sarah Barnett, M.S., CGC

176

Rising rates of group A streptococcus and antibiotic resistant gonorrhea: Dr. Robin Patel

177

Chromosomal microarray better informs brain tumor diagnosis: Robert Jenkins, M.D., Ph.D.

178

When to test for norovirus: Dr. Bill Morice

179

THCU: Paul Jannetto, Ph.D., and Loralie Langman, Ph.D.

180

Sharing Mayo Clinic knowledge globally while learning from other cultures: Dr. Bill Morice

181

Novel biomarkers added to movement disorders profile: Andrew McKeon, M.B., B.Ch., M.D.

182

How digital pathology is changing patient care at Mayo Clinic: Dr. Joaquin Garcia

183

New gene panel enhances brain tumor profiles: Cristiane (Cris) Ida, M.D.

184

Triple-demic update and the future of at-home testing: Dr. Bill Morice

185

Recap of this year’s J.P. Morgan Healthcare Conference and COVID-19 update: Dr. Bill Morice

186

Novel panel identifies toxins linked to asthma and GI diseases: Melissa Snyder, Ph.D.

187

Legislative update and at-home testing: Dr. Bill Morice

188

Why cancer death rates are declining: Dr. Ansell

189

Respiratory virus update and a new measles test: Dr. Matthew Binnicker

190

Predictions for 2023: Dr. Bill Morice

191

The laboratory’s role in spurring innovation: Dr. Bill Morice

192

Respiratory illness updates and health care economics: Dr. Bill Morice

193

Ensuring quality in the lab: Dr. Bill Morice

194

Liquid biopsy offers noninvasive DNA testing for cancer care: Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D.

195

Staying safe during the holidays: Dr. Bill Morice

196

Carrier Screening: Linda Hasadsri, M.D., Ph.D.

197

The challenges facing most health care leaders: Dr. Bill Morice

198

Novel malabsorption panel speeds diagnosis: Puanani Hopson, D.O.

199

Legislation, leadership, and MayoComplete: Dr. Bill Morice

200

Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.

201

Testing is essential in the months ahead: Dr. Bill Morice

202

Melanoma panel provides more tumor information: Ruifeng (Ray) Guo, M.D., Ph.D.

203

Colorectal panel provides detailed cancer information: Rondell Graham, M.B.B.S.

204

Focused lung panel informs the use of targeted cancer therapies: Ying-Chun Lo, M.D., Ph.D.

205

Unique pediatric evaluation targets relevant autoimmune/CNS antibodies: Andrew McKeon, M.B., B.Ch., M.D.

206

Preparing for respiratory infection season: Dr. Matthew Binnicker

207

Chain of Custody Testing: Loralie Langman, Ph.D.

208

Shifting from pandemic to endemic: Dr. Bill Morice

209

Virus outlook heading into fall: Dr. Bill Morice

210

Advocating for lab legislation: Dr. Bill Morice

211

PIK3CA assay guides treatment of progressing breast cancer: Katherine Geiersbach, M.D.

212

Leading diagnostics into the future: Dr. Bill Morice

213

PCD test provides definitive diagnosis of a rare disease: Joseph Maleszewski, M.D., and Marie-Christine Aubry, M.D.

214

PETH: Paul Jannetto, Ph.D.

215

Looking at the big picture: Dr. Bill Morice

216

Precision therapeutics can individualize depression treatment: Ann Moyer, M.D., Ph.D., and Paul Jannetto, Ph.D.

217

State-of-the-art genetics panel optimizes kidney disease treatment: Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC

218

Monkeypox and legislation updates: Dr. Bill Morice

219

CIDP: Divyanshu (Div) Dubey, M.B.B.S.

220

Ongoing evolution of monkeypox: Dr. Bill Morice

221

PMND1: John Lieske, M.D.

222

Monkeypox testing progress: Dr. Bill Morice

223

Enhanced detection of genetic mutation to optimize leukemia treatment: Rong He, M.D.

224

Operationalizing monkeypox testing: John Osborn

225

Nonradioactive assay helps diagnose heparin reaction: Rajiv Pruthi, M.B.B.S.

226

Monkeypox declared a global public health emergency: Dr. Bill Morice

227

FDA-approved test expands options for Alzheimer's disease: Joshua Bornhorst, Ph.D.

228

Managing the current rise in COVID cases: Dr. Bill Morice

229

Scaling monkeypox testing and the new COVID variant: Dr. Bill Morice

230

New SALSA bill and monkeypox testing at Mayo: Dr. Bill Morice

231

The Latest on Monkeypox and Lab Legislation: Dr. Bill Morice

232

The age of pandemics: Dr. Bill Morice

233

WESDX: Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC

234

Monkeypox: Dr. Bill Morice

235

Being Mindful of Mental Health: John Black, M.D.

236

Viruses and variants: Dr. Bill Morice

237

Recent Outbreaks of Viral Infections: Dr. Matt Binnicker

238

VALID Act: Dr. Bill Morice

239

Tick-borne Disease Testing: Elitza Theel, Ph.D.

240

Lab Legislation Update: Dr. Bill Morice

241

NFLC: Alicia Algeciras, Ph.D.

242

Lab Medicine’s Role in the Clinical Practice: Dr. Bill Morice

243

ADMPU: Loralie Langman, Ph.D., and Paul Jannetto, Ph.D.

244

Regulation of Lab Developed Tests: Dr. Bill Morice

245

Advancements in autoimmune neurology: Dr. Andrew McKeon

246

COVID-19 Update: Dr. Bill Morice

247

IBDP2: Melissa Snyder, Ph.D.

248

CLIA-Licensed Laboratories: Dr. Bill Morice

249

Chromium and Cobalt: Paul Jannetto, Ph.D.

250

Laboratory Innovation: Dr. Bill Morice

251

TPNUQ: Ann Moyer, M.D., Ph.D.

252

Lab developed tests: Dr. Bill Morice

253

MSP3: Maria Alice Willrich, Ph.D.

254

New COVID-19 variants: Dr. Bill Morice

255

Oversight of the laboratory industry: Dr. Bill Morice

256

Urinary ammonium testing: John Lieske, M.D.

257

New Strategies to Combat COVID-19: Dr. Bill Morice

258

New Masking Guidelines: Dr. Bill Morice

259

Extended spectrum beta lactamase testing: Audrey Schuetz, M.D.

260

Informatics and Laboratory Medicine: Dr. David McClintock

261

Stiff-Person/PERM Evaluation: Andrew McKeon, M.B., B.Ch., M.D.

262

Adapting as COVID-19 Changes: Dr. Bill Morice

263

Interpreting Lab Test Results: Dr. Bill Morice

264

Tackling COVID-19 Misinformation: Dr. Bill Morice

265

A Global Perspective on COVID-19: Dr. Bill Morice

266

COVID-19 Antigen Tests: Dr. Bill Morice

267

SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) testing: Joseph Yao, M.D.

268

Respiratory Virus Testing: Dr. Matthew Binnicker

269

Omicron Update: Dr. Bill Morice

270

Reflections on how far we’ve come: Dr. Bill Morice

271

Autoimmune Axonal Testing: Divyanshu (Div) Dubey, M.B.B.S.

272

At-Home COVID-19 Tests: Dr. Brad Karon

273

Holiday Safety and COVID-19: Dr. Bill Morice

274

The State of COVID-19 Now: Dr. Bill Morice

275

Omicron Variant: Dr. Bill Morice

276

CYPZ: Michelle Kluge, M.S., CGC

277

Lab-Developed Tests: Shannon Bennett

278

Hereditary Oncology Testing: Wei Shen, Ph.D.

279

COVID-19 Antibody Testing: Dr. Elitza Theel

280

IDENT: Audrey Schuetz, M.D.

281

COVID-19, Moving Forward: Dr. Bill Morice

282

The State of COVID-19 Today: Dr. Bill Morice

283

The Global Impact of COVID-19: Dr. Bill Morice

284

NF155: John Mills, Ph.D.

285

How AI is Shaping the Future of Laboratory Medicine: Dr. Bill Morice

286

Mitochondrial disease: Linda Hasadsri, M.D., Ph.D.

287

The Value of a Flu Vaccine Amid COVID-19: Dr. Bill Morice

288

T-cell Lymphoma Testing: Dr. Andrew Feldman

289

COVID-19 National Strategy: Dr. Bill Morice

290

PGXQP: Ann Moyer, M.D., Ph.D.

291

COVID-19 Vaccine Myths: Dr. Bill Morice & Dr. Matt Binnicker

292

COVID-19 Vaccine Boosters: Dr. Bill Morice

293

Candida Auris: Dr. Nancy Wengenack

294

COVID-19 Breakthrough Infections: Dr. Bill Morice

295

COVID-19 Update: Dr. Bill Morice

296

MAG Antibody Testing: John Mills, Ph.D.

297

COVID-19 Surge: Dr. Bill Morice

298

Coronavirus Delta Variant: Dr. Bill Morice

299

Vector-Borne Diseases: Dr. Bobbi Pritt & Dr. Bill Morice

300

Disaccharidase Activity Panel: Puanani (Pua) E. Hopson, D.O.

301

Lab fee reimbursement: Dr. Bill Morice

302

Kelch-11: Divyanshu (Div) Dubey, M.B.B.S.

303

The Current State of COVID-19: Dr. Bill Morice

304

NELL-1: Sanjeev Sethi, M.D., Ph.D.

305

Leading in Laboratory Medicine: Dr. Bill Morice

306

West Nile virus PCR testing: Bobbi Pritt, M.D.

307

MayoComplete Solid Tumor Panel: Kevin C. Halling, M.D., Ph.D.

308

Mayo Clinic, Thermo Fisher Collaboration: Dr. Bill Morice

309

Laboratory Medicine After COVID-19: Dr. Bill Morice

310

TMA: Meera Sridharan, M.D., Ph.D.

311

Mayo Clinic Laboratories: Dr. Bill Morice

312

Lab Innovation During COVID-19: Dr. Bill Morice

313

Autoimmune Profile Updates: Andrew McKeon, M.B., B.Ch., M.D.

314

COVID-19 Vaccine Safety: Dr. Bill Morice

315

COVID-19 Testing Update: Joseph Yao, M.D.

316

Vaccine Passports: Dr. Bill Morice

317

Myasthenia Gravis: Christopher Klein, M.D.

318

COVID-19 Vaccine Update: Dr. Bill Morice

319

COVID-19 Vaccine Hesitancy: Dr. Bill Morice

320

The Path to Leadership: Dr. Bill Morice

321

Female Leadership at Mayo Clinic: Dr. Bill Morice

322

The Future of Lab Medicine Beyond COVID-19: Dr. Bill Morice

323

How COVID-19 Changed the Future of Lab Medicine: Dr. Bill Morice

324

Paraneoplastic Vision Loss Evaluation: Andrew McKeon, M,B., B.Ch., M.D.

325

The Impact of COVID-19 Variants: Dr. Matthew Binnicker

326

MASS-FIX: David Murray, M.D., Ph.D.

327

National COVID-19 Strategy: Dr. Bill Morice

328

Debunking COVID-19 Vaccine Myths: Dr. Bill Morice

329

Pancreatic Elastase Test: Puanani Hopson, D.O.

330

Laboratory Medicine in 2021 and Beyond: Dr. Bill Morice

331

COVID-19 Variants: Dr. Bill Morice

332

2020 COVID-19 Recap: Dr. Bill Morice

333

Dendritic Cell Enumeration Test: Amir Sadighi Akha, M.D., D.Phil.

334

Soaring Interest in Health Care Professions: Dr. Bill Morice

335

Updated Testing Algorithms for Plasma Cell Proliferative Disorders: Xinjie Xu, Ph.D.

336

Debunking Mask Myths: Dr. Bill Morice

337

Paraffin-Embedded Tissue Testing for COVID-19: Anja Roden, M.D.

338

Masks and COVID-19 Prevention: Dr. Bill Morice

339

Hereditary Hearing Loss: Nicole Boczek, Ph.D.

340

COVID-19 Vaccine Update: Dr. Bill Morice

341

COVID-19 Antibody Testing Update: Elitza Theel, Ph.D.

342

Treatment for COVID-19: Dr. Bill Morice

343

Alpha-Gal Testing: Joshua Bornhorst, Ph.D.

344

COVID-19 and Herd Immunity: Dr. Bill Morice

345

Distinguishing COVID-19 From Other Respiratory Illnesses: Aaron Tande, M.D.

346

COVID-19 Testing 101: Dr. Bill Morice

347

B-Cell Lymphoblastic Leukemia Monitoring for Minimal Residual Disease: Min Shi, M.D., Ph.D.

348

Enjoying Fall Activities Safely During COVID-19: Dr. Bill Morice

349

Coagulopathies and COVID-19: Nahla Heikal, M.D.

350

Staying Safe Amid a Surge in COVID-19: Dr. Bill Morice

351

MDM2 Gene Amplification: William Sukov, M.D.

352

Behind the Scenes in a Processing Lab During COVID-19: Jonathan Berry

353

COVID-19 – At-Home Sample Collection vs. At-Home Testing: Dr. Bill Morice

354

COVID Testing at Home: Dr. Bill Morice

355

Different Forms of Masking: Dr. Bill Morice

356

Quality Management during COVID-19: Jill Hill

357

Screening and Surveillance Testing: Dr. Bill Morice

358

Labor Day Weekend Precautions: Dr. Bill Morice

359

Laboratory Perspective of COVID-19: Aimee Boerger and Emily Fernholz

360

Leadership in a Time of Uncertainty: Dr. Bill Morice

361

Maximizing Testing Capacity: Dr. Bill Morice

362

Herd Immunity: Dr. Bill Morice

363

600th Case of the Week on Creepy Dreadful Wonderful Parasites: Dr. Bobbi Pritt

364

Pooling and Precautions: Dr. Bill Morice

365

Benefits of Wearing a Mask: Dr. Bill Morice

366

Supply Chain Management during COVID-19: Dr. Paul Jannetto

367

Delta Air Lines Partnership: Dr. Bill Morice

368

Neutralizing Antibody Assay, Explained: Dr. John Mills

369

Future of COVID-19 Laboratory Testing: Dr. Bill Morice

370

New COVID-19 Test Launch and Employee Testing: Dr. Bill Morice

371

Serology Testing for COVID-19: Dr. Elitza Theel

372

Innovation in COVID-19 Testing: Dr. Bill Morice

373

Using COVID-19 Testing to Help Restart the Economy: Dr. Bill Morice

374

Microbiology Leadership during the COVID-19 Pandemic: Dr. Robin Patel

375

Evolution of the COVID-19 Pandemic: Dr. Bill Morice

376

Podcasting Discussion with the Bow Tie Bandit of Blood: Dr. Justin Kreuter

377

State-Level Testing for COVID-19: Dr. Bill Morice

378

Increased PCR Testing Capacity for COVID-19: Dr. Joseph Yao

379

Leadership and Collaboration During COVID-19: Dr. Bill Morice

380

Drive-up Phlebotomy Services for Serology Testing: Nicole Kang

381

Minnesota Partnership for COVID-19 Pandemic: Dr. Bill Morice

382

Understanding COVID-19 Testing Options: Dr. Matt Binnicker

383

Leadership during the COVID-19 Pandemic: Dr. Bill Morice

384

Serology Testing for COVID-19: Dr. Elitza Theel

385

Coming Soon: Answers from the Lab Podcast